<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Sindrome di Hunter, Italfarmaco e Jcr Pharmaceuticals insieme per terapia sperimentale﻿	</title>
	<atom:link href="https://ugualmenteabile.it/2026/10/02/sindrome-di-hunter-italfarmaco-e-jcr-pharmaceuticals-insieme-per-terapia-sperimentale/feed/" rel="self" type="application/rss+xml" />
	<link>https://ugualmenteabile.it/2026/10/02/sindrome-di-hunter-italfarmaco-e-jcr-pharmaceuticals-insieme-per-terapia-sperimentale/</link>
	<description>Ugualmente Abile news, servizi, eventi, iniziative</description>
	<lastBuildDate>Fri, 02 Oct 2026 10:23:27 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>
</channel>
</rss>
